Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Jun 29, 2019 10:15am
101 Views
Post# 29875944

RE:Can anyone explain to me----

RE:Can anyone explain to me----The outstanding common shares of Theralase (“Common Shares”) trade on the TSX Venture Exchange (“TSXV”) under the symbol “TLT” and on the OTCQB marketplace under the symbol “TLTFF”. On June 24, 2019, the last trading day prior to the date of this Prospectus, the closing price of the Common Shares on the TSXV was $0.50 and on the OTCQB marketplace was US$0.39. The Corporation has applied to list (i) the Unit Shares (including any Over-Allotment Shares (as defined herein) issuable upon exercise of the Over-Allotment Option (as defined herein) and any Compensation Option Shares (as defined herein) issuable upon exercise of the Compensation Options (as defined herein)), (ii) the Warrants (including any Over-Allotment Warrants (as defined herein) issuable upon exercise of the Over-Allotment Option and any Compensation Option Warrants (as defined herein) issuable upon exercise of the Compensation Options), and (iii) the Warrant Shares, if and when issued, on the TSXV. Listing is subject to the approval of the TSXV in accordance with its applicable listing requirements

Many have said discount but we could see something more akin to an auction or as one has said "what the market will bear" 50 cents seems to be the marker.
Bullboard Posts